Alcohol consumption4 N(%) | 182 |
|
| 0.50 |
|
| 0.16 |
|
| 0.56 |
None |
| 47/73 (64.4) | 69/109 (63.3) |
| 83/122 (68.0) | 33/60 (55.0) |
| 66/103 (64.1) | 50/79 (63.3) |
|
Normal |
| 7/73 (9.6) | 6/109 (5.5) |
| 9/122 (7.4) | 4/60 (6.7) |
| 9/103 (8.7) | 4/79 (5.1) |
|
Excessive |
| 19/73 (26.0) | 34/109 (31.2) |
| 30/122 (24.6) | 23/60 (38.3) |
| 28/103 (27.2) | 25/79 (31.7) |
|
Other preventive care | ||||||||||
Regular aspirin therapy N(%) | 292 | 68/101 (67.3) | 115/191 (60.2) | 0.23 | 109/173 (63.0) | 74/119 (62.2) | 0.89 | 108/163 (66.3) | 75/129 (58.1) | 0.15 |
Lipid measurements at least 1x/2 years N(%) | 292 | 97/101 (96.0) | 178/191 (93.2) | 0.32 | 163/173 (94.2) | 112/119 (94.1) | 0.97 | 156/163 (95.7) | 119/129 (92.2) | 0.21 |
Blood sugar monitoring at home if insulin therapy N(%) | 292 | 0.08 | <0.001 | 0.38 | ||||||
yes | 43/101 (42.6) | 58/191 (30.4) | 75/173 (43.4) | 26/119 (21.9) | 62/163 (38) | 39/129 (30.2) | ||||
no | 0/101 | 2/191 (1.1) | 0/173 | 2/119 (1.7) | 1/163 (0.6) | 1/129 (0.8) | ||||
non applicable5 | 58/101 (57.4) | 131/191 (68.6) | 98/173 (56.7) | 91/119 (76.5) | 100/163 (61.3) | 89/129 (69) | ||||
Follow-up visit at least 2x/year N(%) | 292 | 95/101 (94.1) | 164/191 (85.8) | 0.035 | 164/173 (94.8) | 95/119 (79.7) | <0.001 | 148/163 (90.8) | 111/129 (86) | 0.2 |
Hb1Ac at least 2x/year N(%) | 292 | 83/101 (82.2) | 127/191 (66.5) | 0.005 | 137/173 (79.2) | 73/119 (61.3) | 0.001 | 124/163 (76.1) | 86/129 (66.7) | 0.08 |
Urine microalbumin/creatinine ratio at least 1x/2 years N (%) | 291 | 64/101 (63.4) | 137/190 (72.1) | 0.13 | 118/173 (68.2) | 83/118 (70.3) | 0.70 | 111/162 (68.5) | 90/129 (69.8) | 0.66 |